Robert W. Selander - 23 Jun 2022 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Reporting relationship: Director
Issuer ticker: HQY
Reported as of: 23 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jun 2022, 19:46:17 UTC
Prior SEC filing: 09 May 2022
Next SEC filing: 26 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Delano W. Ladd, Attorney-in-Fact

Key filing fact

Robert W. Selander filed Form 4 for HEALTHEQUITY, INC. (HQY) on 27 Jun 2022.

Key facts

This page summarizes Robert W. Selander's Form 4 filing for HEALTHEQUITY, INC. (HQY).
1 reported transaction and 2 derivative rows are listed below.
Accepted by SEC: 27 Jun 2022, 19:46.

Change

Previous filing in this sequence was filed on 09 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HQY transaction

Common Stock

Award

Transaction value: $0
Shares: +2,996
Change %: +7.6%
Price: $0.000000
Shares after: 42,262
Date: 23 Jun 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HQY holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50,000
Date: 23 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $28.68
Footnotes: F2

HQY holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,000
Date: 23 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $21.27
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's next annual stockholder meeting, which is expected to be held in June of 2023. Vested shares will be delivered to the reporting person upon vesting.

Footnote F2

The option is immediately exercisable.

SEC remarks

The power of Attorney given by Ms. McCowan was previously filed with the U.S. Securities and Exchange Commission on April 3, 2018 as an exhibit to a statement on Form 3 filed by Ms. McCowan with respect to HealthEquity, Inc. and is hereby incorporated by reference.